113 related articles for article (PubMed ID: 17545547)
1. The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.
Baker AF; Landowski T; Dorr R; Tate WR; Gard JM; Tavenner BE; Dragovich T; Coon A; Powis G
Clin Cancer Res; 2007 Jun; 13(11):3388-94. PubMed ID: 17545547
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.
Dvorakova K; Payne CM; Tome ME; Briehl MM; Vasquez MA; Waltmire CN; Coon A; Dorr RT
Mol Cancer Ther; 2002 Jan; 1(3):185-95. PubMed ID: 12467213
[TBL] [Abstract][Full Text] [Related]
3. Induction of mitochondrial changes in myeloma cells by imexon.
Dvorakova K; Waltmire CN; Payne CM; Tome ME; Briehl MM; Dorr RT
Blood; 2001 Jun; 97(11):3544-51. PubMed ID: 11369649
[TBL] [Abstract][Full Text] [Related]
4. Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cells.
Dvorakova K; Payne CM; Landowski TH; Tome ME; Halperin DS; Dorr RT
Anticancer Drugs; 2002 Nov; 13(10):1031-42. PubMed ID: 12439337
[TBL] [Abstract][Full Text] [Related]
5. Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.
Evens AM; Prachand S; Shi B; Paniaqua M; Gordon LI; Gartenhaus RB
Clin Cancer Res; 2004 Feb; 10(4):1481-91. PubMed ID: 14977852
[TBL] [Abstract][Full Text] [Related]
6. Induction of oxidative stress and apoptosis in myeloma cells by the aziridine-containing agent imexon.
Dvorakova K; Payne CM; Tome ME; Briehl MM; McClure T; Dorr RT
Biochem Pharmacol; 2000 Sep; 60(6):749-58. PubMed ID: 10930529
[TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor activity, pharmacokinetics and pharmacodynamics of imexon in mice.
Pourpak A; Meyers RO; Samulitis BK; Sherry Chow HH; Kepler CY; Raymond MA; Hersh E; Dorr RT
Anticancer Drugs; 2006 Nov; 17(10):1179-84. PubMed ID: 17075317
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 induces antioxidant gene expression and resistance to oxidative stress.
Bae I; Fan S; Meng Q; Rih JK; Kim HJ; Kang HJ; Xu J; Goldberg ID; Jaiswal AK; Rosen EM
Cancer Res; 2004 Nov; 64(21):7893-909. PubMed ID: 15520196
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines.
Dorr RT; Raymond MA; Landowski TH; Roman NO; Fukushima S
Int J Gastrointest Cancer; 2005; 36(1):15-28. PubMed ID: 16227632
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression in apoptosis of human lymphoma U937 cells induced by heat shock and the effects of alpha-phenyl N-tert-butylnitrone (PBN) and its derivatives.
Hirano H; Tabuchi Y; Kondo T; Zhao QL; Ogawa R; Cui ZG; Feril LB; Kanayama S
Apoptosis; 2005 Mar; 10(2):331-40. PubMed ID: 15843894
[TBL] [Abstract][Full Text] [Related]
11. Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma.
Moehler TM; Feneberg R; Ho AD; Golenkov AK; Ludwig H; Kropff M; Khuageva NK; Hajda J; von Broen I; Goldschmidt H
Anticancer Drugs; 2010 Aug; 21(7):708-15. PubMed ID: 20571355
[TBL] [Abstract][Full Text] [Related]
12. Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.
Cho H; Koto M; Riesterer O; Molkentine DP; Giri U; Milas L; Story MD; Ha CS; Raju U
Anticancer Res; 2009 Nov; 29(11):4409-15. PubMed ID: 20032386
[TBL] [Abstract][Full Text] [Related]
13. Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells.
Sheveleva EV; Landowski TH; Samulitis BK; Bartholomeusz G; Powis G; Dorr RT
Mol Cancer Res; 2012 Mar; 10(3):392-400. PubMed ID: 22275514
[TBL] [Abstract][Full Text] [Related]
14. Areca nut extracts increased the expression of cyclooxygenase-2, prostaglandin E2 and interleukin-1α in human immune cells via oxidative stress.
Chang LY; Wan HC; Lai YL; Chou IC; Chen YT; Hung SL
Arch Oral Biol; 2013 Oct; 58(10):1523-31. PubMed ID: 23916228
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro.
Hersh EM; Gschwind CR; Taylor CW; Dorr RT; Taetle R; Salmon SE
J Natl Cancer Inst; 1992 Aug; 84(16):1238-44. PubMed ID: 1640482
[TBL] [Abstract][Full Text] [Related]
16. Correlates of imexon sensitivity in human multiple myeloma cell lines.
Samulitis BK; Landowski TH; Dorr RT
Leuk Lymphoma; 2006 Jan; 47(1):97-109. PubMed ID: 16321833
[TBL] [Abstract][Full Text] [Related]
17. ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element.
Wilson LA; Gemin A; Espiritu R; Singh G
FASEB J; 2005 Dec; 19(14):2085-7. PubMed ID: 16234432
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin induced antioxidant gene expressions in human lens epithelial cells.
Yegorova S; Yegorov O; Lou MF
Exp Eye Res; 2006 Oct; 83(4):783-92. PubMed ID: 16712839
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
Krysan K; Lou MF
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling.
Aitken CJ; Hodge JM; Nishinaka Y; Vaughan T; Yodoi J; Day CJ; Morrison NA; Nicholson GC
J Bone Miner Res; 2004 Dec; 19(12):2057-64. PubMed ID: 15537450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
